ProQR Therapeutics (PRQR) Enterprise Value Growth (1y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 32.62% |
| Dec 31, 2024 | -24.77% |
| Dec 31, 2023 | -30.59% |
| Sep 30, 2023 | 30.50% |
| Jun 30, 2023 | 16.00% |
| Mar 31, 2023 | 28.92% |
| Dec 31, 2022 | 55.28% |
| Sep 30, 2022 | -13.23% |
| Jun 30, 2022 | -79.18% |
| Mar 31, 2022 | -130.41% |
| Dec 31, 2021 | -139.65% |
| Sep 30, 2021 | -26.56% |
| Jun 30, 2021 | 24.35% |
| Mar 31, 2021 | 99.93% |
| Dec 31, 2020 | 26.22% |
| Sep 30, 2020 | -12.39% |
| Jun 30, 2020 | -3.94% |
| Mar 31, 2020 | -102,883.78% |
| Dec 31, 2019 | -2.83% |
| Sep 30, 2019 | -109.99% |
| Jun 30, 2019 | -106.67% |
| Mar 31, 2019 | 100.00% |
| Dec 31, 2018 | -112.79% |
| Sep 30, 2018 | 100.00% |
| Jun 30, 2018 | -88,186,342.28% |
| Mar 31, 2018 | -93,688,349,333.65% |
| Dec 31, 2017 | 11.40% |
| Sep 30, 2017 | -95,997,909,128.97% |
| Dec 31, 2016 | 38.53% |
| Sep 30, 2016 | 100.00% |
| Dec 31, 2015 | 26.20% |
| Sep 30, 2015 | -247,259.50% |
| Mar 31, 2015 | -2,172.65% |
| Dec 31, 2014 | -2,407.17% |
| Sep 30, 2014 | -1,338.81% |